Literature DB >> 24859540

Autoimmune pulmonary proteinosis in a Chilean teenager, a rare aetiology of interstitial lung disease.

Alexis Strickler1, Maria Lina Boza2, Andres Koppmann2, Sergio Gonzalez3.   

Abstract

Interstitial lung disease (ILD) is rare and encompasses a heterogeneous group of diseases, and is even rarer in children than in adults. ILDs compromise more than 100 different entities, including pulmonary alveolar proteinosis (PAP). There are many causes of PAP in children, including surfactant protein gene mutations (SFTPB, SFTPC, ABCA3, TTF-1), GMCSF receptor mutations and antigranulocyte-macrophage colony-stimulating factor autoantibodies. We report a case of a 13-year-old Chilean girl who presented with an 8-month history of progressive exercise intolerance, fatigability and diminished school performance. Physical examination revealed resting tachypnoea, a few basal bilateral inspiratory crackles, and hypoxaemia on minimal exertion. Clinical suspicion and evaluation, including international collaboration, led to the diagnosis of autoimmune PAP and specific therapy for the condition. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24859540      PMCID: PMC4039768          DOI: 10.1136/bcr-2012-006987

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  36 in total

1.  Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease.

Authors:  S J Copley; M Coren; A G Nicholson; M B Rubens; A Bush; D M Hansell
Journal:  AJR Am J Roentgenol       Date:  2000-02       Impact factor: 3.959

Review 2.  How to evaluate and treat children's interstitial lung disease.

Authors:  Robin Deterding
Journal:  Paediatr Respir Rev       Date:  2006-06-05       Impact factor: 2.726

3.  Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons?

Authors:  Anthony Meager; Isabelle Cludts; Robin Thorpe; Meenu Wadhwa
Journal:  Blood       Date:  2010-01-14       Impact factor: 22.113

4.  Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.

Authors:  Haruyuki Ishii; Bruce C Trapnell; Ryushi Tazawa; Yoshikazu Inoue; Masanori Akira; Yoshihito Kogure; Keisuke Tomii; Toshinori Takada; Masayuki Hojo; Toshio Ichiwata; Hajime Goto; Koh Nakata
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

5.  Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Authors:  Yoshikazu Inoue; Bruce C Trapnell; Ryushi Tazawa; Toru Arai; Toshinori Takada; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masaaki Hojo; Toshio Ichiwata; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Kazunori Oishi; Yoshiko Tsuchihashi; Chinatsu Kaneko; Toshihiro Nukiwa; Mitsunori Sakatani; Jeffrey P Krischer; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

6.  GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.

Authors:  Kanji Uchida; David C Beck; Takashi Yamamoto; Pierre-Yves Berclaz; Shuichi Abe; Margaret K Staudt; Brenna C Carey; Marie-Dominique Filippi; Susan E Wert; Lee A Denson; Jonathan T Puchalski; Diane M Hauck; Bruce C Trapnell
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

Review 7.  Treatment of interstitial lung disease in children.

Authors:  R Dinwiddie
Journal:  Paediatr Respir Rev       Date:  2004-06       Impact factor: 2.726

8.  Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

Authors:  Takuro Sakagami; Kanji Uchida; Takuji Suzuki; Brenna C Carey; Robert E Wood; Susan E Wert; Jeffrey A Whitsett; Bruce C Trapnell; Maurizio Luisetti
Journal:  N Engl J Med       Date:  2009-12-31       Impact factor: 91.245

9.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

10.  Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.

Authors:  Takuji Suzuki; Takuro Sakagami; Bruce K Rubin; Lawrence M Nogee; Robert E Wood; Sarah L Zimmerman; Teresa Smolarek; Megan K Dishop; Susan E Wert; Jeffrey A Whitsett; Gregory Grabowski; Brenna C Carey; Carrie Stevens; Johannes C M van der Loo; Bruce C Trapnell
Journal:  J Exp Med       Date:  2008-10-27       Impact factor: 14.307

View more
  2 in total

1.  Autoimmune pulmonary alveolar proteinosis in children.

Authors:  Matthias Griese; Panagiota Panagiotou; Effrosyni D Manali; Mirjam Stahl; Nicolaus Schwerk; Vanessa Costa; Konstantinos Douros; Maria Kallieri; Ruth Maria Urbantat; Horst von Bernuth; Lykourgos Kolilekas; Lurdes Morais; Ana Ramos; Kerstin Landwehr; Katrin Knoflach; Florian Gothe; Karl Reiter; Vassiliki Papaevangelou; Athanasios G Kaditis; Christina Kanaka-Gantenbein; Spyros A Papiris
Journal:  ERJ Open Res       Date:  2022-03-21

2.  Autoimmune pulmonary alveolar proteinosis successfully treated with lung lavage in an adolescent patient: a case report.

Authors:  Abdalla Mohmed Alasiri; Reem Abdullah Alasbali; Meaad Ali Alaqil; Aishah Marei Alahmari; Nouf Dagash Alshamrani; Rabab Nasir Badri
Journal:  J Med Case Rep       Date:  2021-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.